Dynavax Technologies Corp (NASDAQ:DVAX)

21.74
Delayed Data
As of May 22
 -0.24 / -1.09%
Today’s Change
13.10
Today|||52-Week Range
26.89
+28.94%
Year-to-Date

Today’s Trading

Previous close21.98
Today’s open21.85
Day’s range21.63 - 22.12
Volume317,708
Average volume (3 months)434,800
Market cap$644.1M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book5.75

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.18+1.36%
CORTCorcept Therapeutics...-0.04-0.68%
RGLSRegulus Therapeutics...+0.10+0.78%
INFIInfinity Pharmaceuti...-0.02-0.16%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateJuly 22, 2015
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers